Soligenix announces positive results for ricin vaccine; MMR vaccination rates fall just shy of CDC's goal;

> The Centers for Disease Control and Prevention recommends that adults receive the whooping cough vaccine. Story

> India's New Drugs Advisory Committee of Vaccine approved 9 proposals for trials and market authorizations. News

> MMR vaccination rates fell just shy of the CDC's goals for children starting kindergarten. Article

> NIH scientists gained a new understanding of the first steps in flu antibody development. Release

> Soligenix announced positive Phase Ib clinical results with RiVax, its vaccine against ricin exposure. Release

And Finally... Researchers at the University of Cape Town in South Africa have pioneered a new drug that could serve as a single-dose malaria vaccine. More

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.